Lecture 4: Mycobacteria and Endocarditis Flashcards

1
Q

Mycobacteria: Management

A
  • Isolated in negative pressure room
  • Treatment with 4 drug therapy initiated: Isoniazid, Rifampin, Pyrazinamide, Ethambutol
    • For treatment resistant mtb: Amikacin and Moxifloxacin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Mtb: Primary Infection

A
  • Ghon complex is lung involvement with lymphadenopathy
  • Over next 2 to 6 weeks cell mediated immunity may control infection. If not, expanding lesion and lung destruction with caseating necrosis
  • Hematogenous spread with miliary disease and seeding of distant sites (brain, bone, liver, kidney, bowel, nodes)
  • Erosion into airways results in infectivity to others via droplets small enough for airborne transmission
  • Mortality rate up to 80% in untreated disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Mtb: Reactivation Disease

A
  • Proliferation of dormant bacteria from initial blood seeding
  • Host immunity is key for reactivation
  • Risk relative to person with positive TB skin test and no risk factors
    • » AIDS: 110 to 170 x
    • » HIV: 50 to 110 x
    • » Transplant: 20 to 70 x
    • » Head and neck cancer 40 x
    • » Silicosis: 30 x
    • » Hemodialysis: 10 to 25 x
    • » Exposure within last 2 years: 15 x
    • » TB scarring on x-ray (upper lobe fibronodular) 6 to 19 x
    • » Tumor necrosis factor inhibitors: 1.7 to 9 x
  • Other risk factors with less than 6 x risk include diabetes, smoking, corticosteroid use > 15 mg / day, gastrectomy, malnutrition (less than 85% ideal body weight)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Mtb: Reactivation Disease Age Risk

A

– Infants (ages ≤1 years): 50 percent
– Children (ages 1 to 2): 12 to 25 percent – Children (ages 2 to 5): 5 percent
– Children (ages 5 to 10): 2 percent
– Age >10 years: 1 to 2 percent

  • Reactivation often in apices of lungs
  • Less caseation and regional lymph node involvement
  • May reactivate in disseminated sites with symptoms related to involved organs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Mtb: Clinical features

A
  • Primary, latent and reactivation pathophysiology described earlier
  • Socioeconomic factors (homeless, IVDU, TB endemic area) all increase risk of disease
  • Fever, cough, weight loss , night sweats, malaise
    • – Sputum may be purulent or have hemoptysis
  • Symptoms are often chronic lasting several weeks before diagnosis
  • Big problem in HIV patients in Africa
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mtb DDx

A

Similar symptoms with presence of granulomas (list is longer)

– Other Mycobacteria (M. avium complex)

– Sarcoidosis

– Endemic fungal infections (Histoplasmosis, Blastomycosis, Coccidiodomycosis)

– Q-fever (Coxiella burnetii)

– Lymphoma

– Foreign body vasculitis from IVDU

– HIV infection with AIDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mycobacterium leprae

A

– Involves skin and peripheral nerves

– Mostly found in developing countries

– Transmission is via respiratory route

– Risk factors

  • Close contact with active case (lepromatous or multibacillary)
  • Exposure to nine banded armadillo in North America
  • Older age
  • Genetic factors which influence type of leprosy experienced

Sx:

  • Hypopigmentation or reddish discoloration
  • Loss of sensation in skin lesion
  • Peripheral neuropathy (paraesthesias)
  • Painless burns or wounds on feet or hands
  • Lumps or swelling of earlobes or face
  • Enlarged peripheral nerve
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Other mycobacteria

A
  • Organisms ubiquitous in environment
  • 4 spectra of infection
    • Lymphadenopathy in children (M. scrofulaceum)
    • Skin lesions by direct inoculation (M. marinum)
    • Infection in lung in elderly (Mycobacterium avium complex)
  • Disease in immunocompromised host
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

thin, IV drug use marks on right and left forearms. No skin findings endocarditis. 2/6 systolic murmur right sternal border. Scattered crackles in lungs. Uterus palpable above umbilicus

– WBC 17.3, Hg 101, platelets 95

– Creatinine 75
– CXR bilateral pneumonia

A

Dx: Endocarditis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Endocarditis: Clinical Features

A

Sx

  • Fever, fatigue, myalgias, arthralgias, weight loss, exercise intolerance, diaphoresis
  • Evidence of embolic phenomena
  • Septic arthritis, brain abscess or stroke, splenic abscess
  • Generalized arthralgias
  • Right sided emboli go to the lung – pleuritic chest pain, cough, shortness of breath

Note: Right sided endocarditis will have the embolic phenomena in the lung so usual peripheral exam findings are often absent unless coincident left sided disease

Dx: FROM Josh C

  • Eyes: Roth spots
  • CVS: new regurgitant murmur, muffled prosthetic valve,
  • pericardial rub, signs of heart failure
  • RESP: signs of septic pulmonary infarcts
  • ABDO: tender splenomegaly
  • Extremities: petechiae, splinter hemorrhages, Janeway lesions, Osler’s nodes
  • NEURO: Focal neurologic deficits
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Endocarditis: Modified Duke’s Criteria

A

Major Criteria

  • Persistent positive blood cultures with organism typical for endocarditis
  • Evidence of endocardial involvement
      • Positive echocardiogram
      • New valvular regurgitation
  • Serologic or culture evidence of Coxiella burnetii infection

Minor Criteria

  • Predisposition: prosthetic heart valve, structural heart disease, IVDU
  • Fever
  • Vascular phenomena - major arterial emboli, septic pulmonary emboli, mycotic aneurysm, intracranial hemorrhage, conjunctival hemorrhage, Janeway lesions
  • Immunologic phenomena - GN, Osler’s nodes, Roth spots, RF
  • Intermittent bacteremia/fungemia

Definite endocarditis

  • Direct evidence on histology or gram stain of vegetation or infected cardiac tissue
  • 2 major criteria
  • 1 major criteria and 3 minor
  • 5 minor criteria

Possible

  • 1 major and 1 or 2 minor criteria
  • 3 minor criteria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Endocarditis: Investigations

A
  • Blood cultures x 3
    • over 1 hour (prior to empiric antibiotic therapy if possible) from 3 different sites.
    • If subacute presentation can hold off antibiotics while investigating.
    • If rapid onset and unwell initiate therapy after cultures collected
  • ESR/CRP -> elevated
  • CBC + peripheral blood smear -> leukocytosis, normochromic normocytic
  • anemia, thrombocytosis or thrombocytopenia
  • Rheumatoid Factor -> elevated
  • Urinalysis -> RBC casts: indicates Glomerulonephritis (GN)
  • ECG
  • – Ischemic changes may indicate emboli to the coronary circulation
  • – New heart block or conduction delay may indicate extension of infection to valve annulus or septum
  • CXR -> focal infiltrates often with central cavitation may indicate septic pulmonary emboli
  • Echocardiogram
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Endocarditis: When to consult for valve replacement

A

– Heart failure related to valve dysfunction

– Severe aortic or mitral valve regurgitation

– Endocarditis due to fungi or highly resistant organisms

– Perivalvular infection with abscess or fistula

– Embolization in spite of antibiotic therapy (weak)

– Vegetation size > 10mm (15mm in Europe) (weakest)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Endocarditis: Predictors of Mortality

A
  • S. aureus infection
  • Heart failure
  • Diabetes
  • Embolic events
  • Perivalvular abscess
  • Large vegetation size
  • Contraindication to surgery
  • Female gender
  • Persistent bacteremia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Endocarditis: Management

A

– IV therapy high dose for several weeks

– For streptococci MIC (minimal inhibitory concentration) important for choice and duration of therapy

– Chose bactericidal agents. Beta lactams often first choice.

– May add aminoglycoside for synergistic killing

– Identification and susceptibilities of organism key